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Abstract
Background: To examine the structural organisation of heterodimeric soluble guanylyl cyclase (sGC) Fo ¨rster resonance
energy transfer (FRET) was measured between fluorescent proteins fused to the amino- and carboxy-terminal ends of the
sGC b1 and a subunits.
Methodology/Principal Findings: Cyan fluorescent protein (CFP) was used as FRET donor and yellow fluorescent protein
(YFP) as FRET acceptor. After generation of recombinant baculovirus, fluorescent-tagged sGC subunits were co-expressed in
Sf9 cells. Fluorescent variants of sGC were analyzed in vitro in cytosolic fractions by sensitized emission FRET. Co-expression
of the amino-terminally tagged a subunits with the carboxy-terminally tagged b1 subunit resulted in an enzyme complex
that showed a FRET efficiency of 10% similar to fluorescent proteins separated by a helix of only 48 amino acids. Because
these findings indicated that the amino-terminus of the a subunits is close to the carboxy-terminus of the b1 subunit we
constructed fusion proteins where both subunits are connected by a fluorescent protein. The resulting constructs were not
only fluorescent, they also showed preserved enzyme activity and regulation by NO.
Conclusions/Significance: Based on the ability of an amino-terminal fragment of the b1 subunit to inhibit activity of an
heterodimer consisting only of the catalytic domains (acatbcat), Winger and Marletta (Biochemistry 2005, 44:4083–90) have
proposed a direct interaction of the amino-terminal region of b1 with the catalytic domains. In support of such a concept of
‘‘trans’’ regulation of sGC activity by the H-NOX domains our results indicate that the domains within sGC are organized in a
way that allows for direct interaction of the amino-terminal regulatory domains with the carboxy-terminal catalytic region.
In addition, we constructed ‘‘fluorescent-conjoined’’ sGC’s by fusion of the a amino-terminus to the b1 carboxy-terminus
leading to a monomeric, fluorescent and functional enzyme complex. To our knowledge this represents the first example
where a fluorescent protein links two different subunits of a higher ordered complex to yield a stoichometrically fixed
functionally active monomer.
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Introduction
Guanylyl cyclase (EC 4.6.1.2) catalyzes the reaction of GTP to
the second messenger molecule cGMP. The pharmacologically
important membrane spanning forms act as cell surface receptors
for extracellular peptides e.g. atrial natriuretic peptide (ANP) [1].
Soluble guanylyl cyclase (sGC) is a time-tested target for drugs like
glyceryl trinitrate that release nitric oxide (NO) (for review see [2]).
Innovative drugs are now being developed clinically that either
sensitize the enzyme for activation by NO or activate the enzyme
independently of NO [3], [4]. The enzyme forms relevant for
treatment of coronary artery disease, (pulmonary) hypertension,
erectile dysfunction or arterial occlusive disease consist of a b1
subunit and an a subunit (either a1 or a2). The most prevalent
heterodimeric form a1/b1 has been purified from native tissue as a
heme containing enzyme and has been characterized extensively
by several groups. Despite enormous interest in the structure of the
enzyme in academia and industry, the heterodimeric holoenzyme
has so far resisted all crystallization attempts.
Current information on the structure of the enzyme comes from
homology models of proteins with a known structure that are
related to functional domains within sGC. The carboxy-terminal
parts of the a1 and b1 subunits are homologous to the C1 and C2
domains of mammalian adenylyl cyclase and a eukaryotic guanylyl
cyclase from Chlamydomonas reinhardtii [5]. The amino-terminal
region is homologous to bacterial O2 sensor proteins and is
therefore referred to as heme nitric oxide oxygen (H-NOX)
binding domain [6], [7]. Homology models for sGC-b1 H-NOX
[6], [8] based on these bacterial proteins suggest that it is central
for full activation by NO [9]. The H-NOX associated domain (H-
NOXA) is a central subdomain flanked by the amino-terminal H-
NOX domain and a carboxy-terminal predicted coiled coil [10],
[11]. H-NOXA domains are found in both sGCa and sGCb1 and
a number of bacterial homologues [12]. Based on the crystal
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histidine kinase from Nostoc punctiforme it has been shown to have
a Per-Arnt-Sim (PAS) fold [13]. For better distinction from H-
NOX we will refer to the H-NOXA domain as the PAS-domain in
the current paper. The PAS domain seems to be involved in
heterodimerization of sGC [13]. Very recently the central coiled
coil region of the sGC b1 subunit has been crystallized as a
homodimer and revealed an anti-parallel arrangement of the
monomers [14]. Nevertheless, based on homology modeling the
authors suggest a parallel arrangement of the coiled coil region in
heterodimeric enzymes as in the membrane bound guanylyl
cyclase forms.
There are at least two alternatives how NO binding to the
amino-terminal b1 H-NOX may influence the conformation of the
carboxy-terminal catalytic domain. The classic idea has been that
NO binding to b1 H-NOX induces a conformational shift of the
whole enzyme that is transmitted to the carboxy-terminal catalytic
domain through the PAS and coiled coil domains. This would be
analogous to membrane bound guanylyl cyclase A where binding
of ANP to the extracellular domain is clearly separated from the
intracellular catalytic domain by the plasma membrane. A more
novel concept is that b1 H-NOX may directly interact with the
catalytic region: Winger and Marletta have expressed and purified
the heterodimeric catalytic domain in E. coli [15]. They could
show that the presence of increasing amounts of the separately
expressed, isolated b1 H-NOX domain led to concentration
dependent inhibition of catalytic activity. Although NO had no
effect on the inhibition by b1 H-NOX they suggested a model
where the H-NOX domain of the b1 subunit interacts directly with
the catalytic domain [15]. A prerequisite of this model would be
close proximity of the H-NOX subdomain and the catalytic region
in the intact heterodimeric enzyme. Although structural homology
models are available for subdomains, an analysis of their relative
position to each other is lacking.
In the current paper we use FRET analysis of fluorescent fusion
proteins to show close proximity of the amino-terminal H-NOX
domains and the catalytic region supporting the model by Winger
and Marletta. In addition, we tested this structural organization by
fusion of the carboxy-terminus of the b1 subunit to the amino-
terminus of the a1 subunit. In accordance with the prediction this
monomeric fusion of the formerly heterodimeric NO-receptor
results in a functional NO-sensitive enzyme. This confirms the
concept of close proximity of H-NOX domains and the catalytic
domain. Our data thus make it likely that significant differences
exist within the guanylyl cyclase family with respect to the
communication of the regulatory molecules NO and ANP from
the amino-terminus to the carboxy-terminus of guanylyl cyclases.
Results
Expression and functional characterization of fluorescent
tagged sGC subunits
A series of fluorescent tagged sGC subunits were constructed
(Supplementary Methods S1) and expressed in Sf9 cells together
with the dimerizing partner subunit. On Western immunoblots
using antibodies directed against the b1, a1, and a2 subunit,
fluorescent-tagged sGC subunits were detected at the expected
molecular masses predicted from their deduced amino acid
sequence (Fig. 1 A–C). By titrating the multiplicity of infection
(MOI) of donor and acceptor tagged sGC subunit baculoviruses
according to Western immunoblot results in coinfected cytosolic
fractions, expression levels of donor and acceptor tagged subunits
were adjusted to equal levels. Expression levels of wild type sGC
and fluorescent tagged sGC subunits were also similar (see Fig. 1
A–C). Spectrofluorometric studies showed that the fusion of CFP
or YFP to the sGC subunits did not alter the spectral properties of
the fluorescent proteins (Supplementary Fig. S1).
To ensure that attaching fluorescent proteins to sGC subunits
would not affect the formation of a functional heterodimeric
enzyme complex, we assayed specific guanylyl cyclase activity.
Specific guanylyl cyclase activity was measured in cytosolic
fractions of infected Sf9 cells under basal conditions, in the
presence of the NO donor DEA/NO (100 mM) or in the presence
of both the NO donor DEA/NO (100 mM) and the sGC
stimulator YC-1 (100 mM). Co-expression of non-tagged sGC a1,
and a2 subunits with the non-tagged sGC b1 subunit resulted in an
activation profile characteristic of the native, heme-containing
enzyme (Fig. 1 D, E). The fluorescent-tagged sGC combinations
aYFP/b1CFP, YFPa/b1CFP displayed NO and NO/YC-1
stimulated sGC activity similar to the non-tagged sGC heterodi-
mer (see Fig. 1 D, E). Co-expression of the a subunit with the
amino-terminal fusion of FP’s to the b1 subunit led to loss of NO
sensitivity with preserved basal activity of the purified enzyme.
Purification of the enzyme complex via Strep-Tag chromatogra-
phy showed that the amino-terminally tagged b1 subunit is capable
to dimerize with the a subunit as shown by Coomassie blue
staining (Fig. 2 A–C). Spectral analysis of the fluorescent-tagged
enzyme complex showed an absorption peak at 515 nm due to
YFP (see Supplementary Fig. S1), but virtually no Soret band
(Fig. 2 D). The apparently heme free enzyme complex showed
basal enzyme activity but, no sensitivity towards NO. Surprisingly
it could not be activated by the heme independent sGC modulator
Cinaciguat (see Fig. 2 E). To confirm preservation of basal activity
of the enzyme complex, specific sGC activity was additionally
measured in the presence of Mn
2+ instead of Mg
2+ as cofactor as
this is known to increase non NO-stimulated activity.
FRET study of fluorescent-tagged sGC variants
To examine if the fluorescent proteins tagged to the termini of
sGC subunits are in proximity to each other we looked for
occurrence of FRET. FRET studies were performed in cytosolic
fractions of Sf9 cells infected with the respective recombinant
baculovirus in a spectrofluorometer at 37uC. As a negative control
for the FRET experiments the fluorescent proteins CFP and YFP
were co-expressed in Sf9 cells. In the respective cytosolic fractions
no FRET was detectable (Fig. 3 A). Cytosolic fractions containing
singly expressed CFP, and YFP, respectively, were mixed in
different ratios. In these additional negative controls no FRET was
detectable (Fig. 3 A). As a FRET positive control we used a sensor
protein based on the cGMP binding domain of the phosphodi-
esterase 5 (PDE 5 A). This fusion protein consists of the 165 amino
acids GAFA domain of phosphodiesterase 5 sandwiched between
CFP and YFP and is similar to cGES-DE5 [16]. After expression
of the YFP-GAFA-CFP fusion protein in Sf9 cells, FRET was
detected in the respective cytosolic fractions. Moreover, FRET
efficiency of YFP-GAFA-CFP increased in a cGMP dependent
manner. Similar to cGES-DE5 the FRET change was about 16%
with EC50-values for cGMP and cAMP of 0.3860.02 mM and
451.5648.8 mM, respectively (Fig. 3 B–D). These results indicate
that the measured FRET in spectrofluorometric studies reflect the
specific energy transfer between CFP and YFP.
sGC a1/b1 isoform. In the a1/b1 enzyme isoform, co-
expression of carboxy-terminally (CC) tagged subunits resulted in
fully active enzyme complexes that showed a FRET efficiency of
14.5% (Fig. 4). Co-expression of amino-terminally (NN) tagged
subunits showed basal activity and a FRET efficiency of 16.4%.
Combinations of amino-terminally and carboxy-terminally tagged
subunits (CN, NC) also showed FRET, but to a significantly lower
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and amino-terminally tagged b1 subunit (CN) showed basal
enzyme activity and a FRET efficiency of 11%. The
combination of amino-terminally tagged a1 subunit and
carboxy-terminally tagged b1 subunit (NC) resulted in the
formation of a fully active enzyme complex that showed a
FRET efficiency of 7.6%. The results from FRET measurements
indicate that the carboxy- and amino-terminal domains of each
subunit (CC, NN) are in closer proximity to each other than the
combinations of amino- and carboxy-terminally tagged subunits
(CN, NC). Nevertheless, occurrence of FRET between the
combinations of amino- and carboxy-terminally tagged subunits
(CN, NC) indicates that these domains are in sufficient close
proximity to allow energy transfer between the fluorescent proteins
(see Fig. 4, Table 1).
sGC a2/b1 isoform. In the a2/b1 enzyme isoform co-
expression of carboxy-terminally (CC) tagged subunits resulted in
fully active enzyme complexes that showed a FRET efficiency of
20.4%. Co-expression of amino-terminally (NN) tagged subunits
showed basal activity and a FRET efficiency of 11.3%. The
combination of carboxy-terminally tagged a2 subunit and amino-
terminally tagged b1 subunit (CN) showed basal enzyme activity and
a FRET efficiency of 17.4%. The combination of the amino-
terminally tagged a1 subunit and carboxy-terminally tagged b1
subunit (NC) resulted in the formation of a fully active enzyme
complexthatshowedaFRETefficiencyof10.1%(seeFig.4,Table1).
Comparison of both sGC isoforms. Comparing the
enzyme isoforms the values for FRET efficiency of the different
fluorescent-tagged combinations are similar, except for the amino-
terminally tagged variants (NN). In the a1/b1 enzyme isoform the
carboxy-terminally tagged variants (CC) and the amino-terminally
tagged variant (NN) show similar FRET efficiencies, while in the
a2/b1 enzyme isoform the FRET efficiency of the carboxy-
terminally tagged variants (CC) are nearly two-fold higher than
the amino-terminally tagged variant (NN). Furthermore, in both
enzyme isoforms carboxy-terminally tagged a subunit co-
expressed with amino-terminally tagged b1 subunit (CN) shows
significantly higher FRET efficiency than the combination of
amino-terminally tagged a subunit and carboxy-terminally tagged
b1 subunit (NC). This indicates that the b1 amino-terminal domain
is in closer proximity to the catalytic domain than the a amino-
terminal domain (see Fig. 4, Table 1). Reference FRET efficiencies
and corresponding calculated distances in A ˚ are included in
Table 1 [17].
Fusion of fluorescent-tagged sGC subunits
The results from the FRET experiments show that the
combinations of amino- and carboxy-terminally (CN, NC)
Figure 1. Analysis of fluorescent tagged heterodimeric sGC subunits in cytosol of infected Sf9 cells. Western blot analysis with
antibodies against the a1 subunit (A) a2 subunit (B) and b1 subunit (C). Specific sGC activity of the a1/b1 heterodimer (D) and the a2/b1 heterodimer
(E) in comparison with the respective fluorescent tagged heterodimeric sGC. The lanes shown for the respective antibody are assembled from the
same Western blot. Data are mean 6 S.E. of three independent experiments performed in duplicate.
doi:10.1371/journal.pone.0011617.g001
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between the fluorescent proteins.
This surprising finding led us to speculate that fusion of the
carboxy-terminus of one subunit to the amino-terminus of the
other subunit may result in an enzyme complex not so different
in conformation from its native counterpart. Our results had
s h o w nt h a tf u s i o na tt h eamino-terminus of the b1 subunit leads
to an enzyme showing no NO sensitivity and activation by
Cinaciguat (see Fig. 2). Since fusion at the amino-terminus of
the a subunit had no influence on the stimulation of the enzyme
by NO and NO/YC-1 (see Fig. 1 D, E), it was the most
promising subunit for amino-terminal fusion. In addition, the
fluorescent proteins tagged to the a amino-terminus and b1
carboxy-terminus (NC) were in sufficient proximity for energy
transfer. On the basis of these results we fused the b1 subunit to
the amino-terminus of the a subunit via a fluorescent protein.
This leads to a single fusion protein consisting of the sGC b1
subunit followed by a fluorescent protein and the sGC a
subunit.
After cloning and generation of recombinant baculovirus we
expressed this monomeric construct in the Sf9/baculovirus system.
Western immunoblots confirmed the expression of a ,180 kDa
protein, which corresponds to the expected molecular mass
predicted from its amino acid sequence (Fig. 5 A–D). To our
surprise, but in accordance with our predictions based on FRET
experiments, enzyme activity assays revealed basal, as well as NO,
and NO/YC-1 stimulated activity (Fig. 5 E). The construct was
designated fluorescent-conjoined sGC.
To examine intramolecular FRET within one polypeptide chain
we additionally fused the FRET donor CFP to the carboxy-
terminus of the fluorescent-conjoined sGC, leading to an enzyme
complex consisting of a b1 subunit followed by a fluorescent
protein and an a subunit followed by another fluorescent protein
with different spectral properties (see Fig. 5 A–D). This double
fluorescent-conjoined sGC showed NO and NO/YC-1 stimulated
activity as well (see Fig. 5 E).
In cytosolic fractions of Sf9 cells infected with one recombinant
virus for the expression of fluorescent-conjoined sGC’s, FRET was
detected confirming that the fluorescent proteins at the a and b1
carboxy-terminus are in close proximity to each other. The
measured FRET efficiencies are 13% and 16.7% for the a1 and a2
fluorescent-conjoined sGC isoform, respectively (see Fig. 4). These
values are slightly lower than the FRET efficiencies of carboxy-
terminally tagged heterodimeric isoforms (14.5% and 20.4%) (see
Fig. 4 and Table 1), indicating a minor change in position or
orientation of the fluorescent protein between the sGC subunits.
Enzyme activity assays showed that the fusion of the b1 carboxy-
terminus to the a amino-terminus does not inhibit the formation of a
functional enzyme complex and does not interfere with the activation
mechanism of the enzyme. This result corroborates our prediction
b a s e do nF R E Tt h a tt h ea m in o - t e r m i n a ld o m a i no ft h easubunit isin
proximity to the carboxy-terminal region of the b1 subunit.
Dynamic changes on activation by NO
We were successful in generating fluorescent fusion proteins of
individual subunits and fluorescent conjoined sGC’s that dynam-
Figure 2. Analysis of purified heterodimeric sGC with an amino-terminally tagged b1 subunit. Coomassie blue staining (A) and Western
blot analysis with antibodies directed against the a1 subunit (B) and the b1 subunit (C) using cytosolic fraction (lane 1) or purified sGC (lane 2).
Absorption spectra of purified sGC under basal conditions (solid line) and in the presence of 100 mM DEA/NO (dotted line) (D). Specific sGC activity of
purified sGC assayed with Mg
2+ (black column) and Mn
2+ (grey column) as cofactor and in the presence of 100 mM DEA/NO (white column) and
10 mM Cinaciguat (dark grey column) (E).
doi:10.1371/journal.pone.0011617.g002
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tions (see Fig. 1 and 5). Despite extensive testing we were not able
to detect any changes in FRET efficiencies on addition of the NO-
donor DEA/NO in concentrations that led to activation in
enzyme activity determinations (data not shown). At the same time
we were able to detect changes in FRET efficiency on addition of
cGMP to YFP-GAFA-CFP which we cloned analogous to cGES-
DE5 [16] (see Fig. 3).
Discussion
Crystal structures of prokaryotic domains with high sequence
similarities to functional domains of sGC have provided invaluable
insights into the structure and possible functions of these isolated
domains [5], [6], [8], [9], [13]. In the absence of structural
information of the heterodimeric sGC holoprotein, the relative
position of these domains to each other is unknown. In the current
paper we use FRET analysis of fluorescent proteins fused to sGC
subunits to study the overall organization of the enzyme as well as
potential dynamic changes on activation by NO.
Dimensions of sGC domains given in Figure 6 are determined
on the basis of crystal structures of sGC homologues (H-NOX,
PDB ID 2O09 [9]; PAS, PDB ID 2P04 [13]; cat, PDB ID 3ET6
[5]) and the structure of the coiled coil domain of the b1 subunit
(PDB ID 3HLS [18]). The catalytic domains form a bulky
structure at the carboxy-terminus of the subunits. FRET between
fluorophores inside fluorescent proteins occurs at a distance of 10–
80 A ˚ [19]. The fluorescent proteins form a barrel that is 42 A ˚ long
and 24 A ˚ in diameter [20]. The chromophores reside in the
middle of the barrel leading to an actual distance between
chromophores in wild-type GFP dimers of 25 A ˚ [21]. Fusion of
fluorescent proteins to the carboxy-termini of a and b subunits
show FRET efficiencies of 15%–20% corresponding to a distance
of 62 A ˚–66 A ˚ (Table 1). These distances fit well to the distance
between the carboxy-termini of crystallized catalytic domain
dimers from Chlamydomonas reinhardtii, which are about 60 A ˚ away
from each other and oriented in opposite directions [5].
The coiled-coil domains consist of 65 amino acids forming an
80 A ˚ long rigid structure [18]. On the amino-terminal side
adjacent to the coiled-coil reside the PAS domains essential for
dimerization followed by the H-NOX domains essential for
enzyme stimulation by NO. On the basis of our FRET
measurements the distance between the fluorophore attached to
the b1 amino-terminus and the fluorophore attached to the a
Figure 3. FRET analysis of positive- and negative control samples in cytosol of infected Sf9 cells. Co-expression (black column) and
mixture (grey columns, CFP emission: YFP emission) of CFP and YFP yielded no FRET (A). Fluorescent spectra of YFP-GAFA-CFP after excitation at
436 nm, before (dotted line) and after addition of 500 mM cGMP (B). The ratio of intensities in the CFP channel and FRET channel decreases after
addition of 500 mM cGMP, indicating an increase in FRET (C). Concentration-response curves of YFP-GAFA-CFP for cGMP and cAMP (n=3) (D).
doi:10.1371/journal.pone.0011617.g003
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sponds to a distance that a helical linker of 28 amino acids creates
between two fluorescent proteins [17]. An elongated organization
analogous to the membrane bound guanylyl cyclase where the
regulatory amino-terminus is clearly separated from the catalytic
domain is not compatible with our data. H-NOX domains, PAS-
domains, coiled coil and catalytic region would result in a distance
of over 200 A ˚ (see Fig. 6 A). The distance from the start of the
fluorescent protein to its fluorescent core is not more than 20 A ˚.
To bring the fluorescent cores in a distance that is predicted by the
calculated FRET efficiency 64–69 A ˚ and that is below the 80 A ˚
necessary for FRET to occur [19], the enzyme has to adopt a more
compact conformation as shown in Figure 6 B.
Likewise the calculated distance based on our FRET results
between a fluorophore attached to the a amino-terminus and a
fluorophore fused to the b1 carboxy-terminus is in a range of 71–
74 A ˚. This corresponds to a distance a helical linker of 48 amino
acids creates between two fluorescent proteins [17]. Again this
argues in favour of a compact enzyme structure where PAS and
H-NOX domains of a and b subunits are folded back towards the
catalytic domain thereby overcoming the distance created by the
rigid coiled coil consisting of a helix of 65 amino acids [18].
Based on the ability of an amino-terminal construct of the b1
subunit (H-NOX) to inhibit activity of a heterodimer consisting
only of the catalytic domains (acatbcat), Winger and Marletta have
proposed a direct interaction of the amino-terminal region of a1
with the catalytic domains [15]. Analysis of our FRET
measurements supports the concept that sGC is structurally
organized in a way that allows for direct interaction of the amino-
terminal (H-NOX) domains of b1 with the carboxy-terminal
catalytic region [15].
The function of the H-NOX domains of a1 and a2 subunits is
not very clear. H-NOX-b1 is known to bind heme via a co-
ordinating histidine [22], [23]. H-NOX-a lacks this histidine and
heme since H-NOX-b1 constructs are sufficient for heme binding
[24] and deletion of the H-NOX domain in a1 does not alter heme
spectra of the purified heterodimeric enzyme [25]. Thus ‘‘heme
binding’’ in the acronym H-NOX does not seem entirely correct
for the H-NOX domain of a1 and a2. However, other members of
the H-NOX superfamily also lack the heme co-ordinating histidine
residue (e.g. in bacterial H-NOX versions from Rhodobacter
sphaeroides and Magnetococcus species (Rhsp 22958463, Mcsp
22999020, [12]). It is conceivable that these domains play a
conserved role in evolution and serve as binding sites for as yet
unidentified substances rather than NO heme. Our FRET analysis
and the enzymatically active fluorescent conjoined fusion protein
suggest that the H-NOX domains of the a subunits could also have
a direct influence on the catalytic domain. Because deletion of the
H-NOX-a domains has surprisingly little influence on the
holoenzyme [25], [26] a modulation of guanylyl cyclase activity
in analogy to the H-NOX domain of b1 is conceivable in the
presence of an as yet not identified ligand or binding protein.
Rothkegel et al. 2007 used an elegant bimolecular fluorescence
complementation (BiFC) approach in a cGMP reporter cell line to
study heterodimerization of sGC a1 and b1 subunit [27].
Fluorescence complementation and catalytic activity occurred
when both halves of the fluorescent protein were fused to the
respective amino-terminus of both sGC subunits. When both halves
of the fluorescent protein were fused to the respective carboxy-
terminus of both subunits, this led to fluorescence complementation
but no catalytic activity. While the study was intended to study
heterodimerization of sGC subunits, it is interesting to compare
Figure 4. FRET analysis of heterodimeric fluorescent tagged
sGC and fluorescent- conjoined sGC variants. FRET efficiencies of
fluorescent tagged sGC heterodimers with the a1 subunit (white
columns), the a2 subunit (grey columns) and conjoined fluorescent
tagged sGC variants (hatched columns). The abbreviations given above
the schematic representations indicate the terminus that is fused to the
fluorescent protein. Data are mean 6 S.E. of at least three independent
experiments.
doi:10.1371/journal.pone.0011617.g004
Table 1. FRET efficiencies of fluorescent-tagged sGC
heterodimers and fluorescent-conjoined sGC.
Efficiency (%) Distance (A ˚)
a1YFP/b1CFP CC 14.5 6 0.8 65.9 6 0.7
a2YFP/b1CFP CC 20.4 6 0.4 61.5 6 0.2
YFP-18aa-CFP * 20.0 61.7
a1YFP/CFPb1 CN 11.0 6 0.3 69.4 6 0.4
a2YFP/CFPb1 CN 17.4 6 0.4 63.6 6 0.3
YFP-28aa-CFP * 13.1 67.1
YFPa1/b1CFP NC 7.6 6 0.3 74.3 6 0.5
YFPa2/b1CFP NC 10.1 6 1.2 70.8 6 1.8
YFP-48aa-CFP * 10.5 70.0
YFPa1/CFPb1 NN 16.4 6 0.6 64.3 6 0.5
YFPa2/CFPb1 NN 11.3 6 0.4 69.1 6 0.5
b1YFPa1CFP Fusion 13.0 6 0.4 67.3 6 0.4
b1YFPa2CFP Fusion 16.7 6 0.5 64.1 6 0.3
CFP/YFP 0.0 6 0.2 n/a
Red marked values are FRET efficiencies of constructs were donor and acceptor
were separated by helical linkers of 18, 28, and 48 amino acids * [17].
doi:10.1371/journal.pone.0011617.t001
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sGC to our FRET approach. Both techniques concordantly
indicate that the amino-terminal regions are closely interacting
and that the carboxy-terminal regions are closely interacting in the
a1/b1 enzyme isoform. Since steric constraints can prevent the
association of the two halves of a fluorescent protein in BiFC, even
when they are close to each other [28], the data by Rothkegel do
not argue against our findings that the amino-terminal and
carboxy-terminal parts of the various subunits are in close
proximity.
To additionally test the proximity of the amino-terminus and
carboxy-terminus suggested by our FRET results, we fused the
carboxy-terminus of the b1 subunit to the amino-terminus of the a
subunit using a fluorescent protein as linker that has an adjacent
amino-terminal start and carboxy-terminal end (see Fig. 5). The
resulting fluorescent-conjoined sGC enzyme showed specific sGC
activity and stimulation by NO or YC-1 similar to the native sGC
enzyme. Since fusion of sGC subunits led to an enzyme complex
with the same properties as the native enzyme, these results further
support the idea that the amino-termini and carboxy-termini of
sGC are in close proximity to each other in the native enzyme.
This is also supported by our recent finding that direct fusion of
subunits of sGC leads to functional enzymes with preserved
biochemical and pharmacological properties ([29] manuscript in
preparation).
In contrast to Rothkegel [27], we were unable to demonstrate
that the amino-terminal fusion of a fluorescent protein to the b1
subunit retained heme and thus NO-sensitivity. Other groups have
also observed impaired heme binding with amino-terminal tags of
the b1 subunit [30], [31]. With regard to catalytic enzyme activity
it is noteworthy that fusion of the fluorescent moieties to the
carboxy-terminus of a1 and b1 subunits suppressed cGMP
formation in BiFC but not in our FRET study [27]. Since
dimerization of the fluorescent halves in BiFC is demonstrated by
fluorescence, we hypothesize that this additional dimerization
interface provided by both fluorescent halves of the fluorescent
protein induces a steric change e.g. closure of the substrate binding
site.
Neither did Rothkegel report any experiments where the effect
of NO was tested on BiFC induced fluorescence, nor did we
observe changes in FRET efficiencies induced by addition of NO
to the various constructs. Our current hypothesis is therefore that
Figure 5. Analysis of fluorescent-conjoined sGC in cytosol of infected Sf9 cells. Western blot analysis with antibodies against the a1 subunit
(A) a2 subunit (B) b1 subunit (C) and fluorescent protein (D). Specific sGC activity of the fluorescent-conjoined sGC variants (E). Data are mean 6 S.E.
of three independent experiments performed in duplicate.
doi:10.1371/journal.pone.0011617.g005
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could argue in favour of proposed activation mechanisms that are
based on modifications of residues by nitrosylation in the catalytic
region rather than extensive conformational changes [32]. NO
binding to heme apparently does not change the relationship of
the fluorophores fused carboxy-terminally to a and b subunits
making a drastic conformational change in the catalytic region
very unlikely. Interpretation of the data including the fluorophore
attached to the b1 subunit is more complicated since this led to a
loss of heme where NO binds (see Fig. 2). It would be conceivable
that the H-NOX domain of the b1 subunit with a heme group has
a distance to the catalytic domain that changes on activation by
NO. This would be the case in a model where NO leads to
derepression of the b1 H-NOX domain. We are currently trying to
use heme as a FRET acceptor and a blue fluorescent protein as a
FRET donor in fluorescence lifetime measurements (FLIM-
FRET) to be able to circumvent fusion of a fluorescent protein
to the amino-terminus of the b1 subunit. While the data in the
current manuscript provide an ideal starting point for such a
strategy, our first series of experiments indicate that this is a
demanding complex project because heme in sGC may not be an
ideal FRET acceptor. Among other problems NO binding
changes absorbance properties of heme and heme containing
subunits and apoforms of the b1 subunit co-exist in vivo.
Fluorescent-conjoined sGCs represent to our knowledge the first
example where a fluorescent protein links two different proteins to
yield a functionally active enzyme. In addition, to having served as
a test system for analyzing the overall structural organization of
sGC the fluorescent-conjoined sGC consisting of one protein chain
containing the b1 and a subunits in series may serve as a powerful
tool for research in the NO/cGMP field.
Materials and Methods
Materials
3-(5-Hydroxymethyl-2-furyl)-1-benzylindazole (YC-1) and 2,2-
Diethyl-1-nitroso-oxyhydrazine (DEA/NO) and all other chemi-
cals, were obtained from Sigma in the highest grade of purity.
Products for Sf9 cell culture were from Invitrogen. Protein
purification was done using A ¨KTA Purifier FPLC-System (GE
Healthcare). Strep-Tactin Superflow was purchased from IBA-
Biotagnology.
Cloning of Fluorescent Tagged Guanylyl Cyclase Subunits
and Generation of Recombinant Baculovirus
Recombinant baculoviruses of respective fluorescent tagged
proteins were generated according to the BAC-TO-BAC
TM
System (Invitrogen). Further information concerning the cloning
of fluorescent tagged proteins can be found in the supplement.
Sf9 Cell Culture, Expression of Recombinant Guanylyl
Cyclase Subunits and Preparation of Cytosolic Fractions
Sf9 cells (Invitrogen Cat.No. 11496-015) were cultured in Sf-
900 II serum-free medium supplemented with 1% penicillin/
streptomycin and 10% fetal calf serum. Spinner cultures were
grown at 27uC at 140 rpm shaking and diluted to 2610
6 cells/ml
for infection. 20 ml of cell solution were infected with the
respective recombinant baculovirus stock. After 74 h cells were
harvested and collected by centrifugation (40006g for 10 min at
4uC). All following steps were performed at 4uC or on ice. The cell
pellet was resuspended in 4 ml of homogenization buffer
containing 50 mM TEA/HCl, pH 7.6, 1 mM EDTA, pH 8.0,
10 mM dithiothreitol, and complete
TM protease inhibitor cocktail
(Roche). The cells were lysed by sonication. Cytosolic fractions
were obtained by centrifugation for 30 min at 21,0006g at 4uC.
Determination of Protein Concentration, Guanylyl
Cyclase Activity, SDS-PAGE, and Western
Immunoblotting
Protein concentrations were determined by the method of
Bradford using bovine serum albumin as standard. sGC activity
of Sf9 cytosol (approximately 60 mg of protein per assay tube) was
determined using isotope labelled [
32P]GTP as described previously
in [25] by incubation for 10 min at 37uC in the presence of 1 mM
cGMP, 0.5 mM [
32P]GTP (about 0.2 mCi), 3 mM MgCl2,5 0m M
Figure 6. Proposed model of the heterodimeric sGC enzyme complex based on the results of FRET analysis and fusion of sGC
subunits. The dimensions of the domains are given on the basis of the crystal structures of domain homologues (H-NOX, PDB ID 2O09 [9]; PAS, PDB
ID 2P04 [13]; cat PDB ID 3ET6 [5]) and the structure of the coiled coil domain of the b1 subunit (PDB ID 3HLS [18]). Elongated model of the sGC (A).
Model according to our results (B). Model of fluorescent-conjoined sGC (C). The b1 subunit is shown in red and the a subunit is shown in blue. cat -
catalytic domain, CC - coiled coil region, PAS - Per-Arnt-Sim fold, HNOX - heme nitric oxide/oxygen binding domain.
doi:10.1371/journal.pone.0011617.g006
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phosphate, and 1 mM 3-isobutyl-1-methylxanthine in a total
volume of 0.1 ml. Reactions were started by the addition of protein
and incubation at 37uC. All experiments were stopped by ZnCO3
precipitation, and purification of the enzyme-formed cGMP was
performed as described previously [33]. Basal enzyme activity
measurements were performed in the absence of NO or YC-1. NO
stimulated measurements were performed in the presence of the
NO donor DEA/NO, and NO/YC-1-stimulated enzyme activity
measurements were performed in the presence of both DEA/NO
and YC-1. YC-1 was dissolved in 25% (v/v) DMSO so that the final
DMSO concentration in the enzyme assay did not exceed 2.5% (v/
v). At this concentration no effects of DMSO on enzyme activity
were observed. DEA/NO was dissolved in 10 mM NaOH, which
also did not affect the enzyme activity.
For immunoblotting, protein fractions were subjected to 10%
SDS-PAGE and then transferred electrophoretically to a nitrocel-
lulose membrane. The membrane was reversibly stained with
Ponceau S, and unspecific binding sites were saturated by
immersing the membrane for 1 h in TBST buffer (10 mM Tris/
HCl, pH 8.0, 150 mM NaCl, 0.05% Tween 20) containing 5%
nonfat dry milk. The membranes were incubated for 1 h in TBST
buffer containing antibodies directed against the b1, a1 (Sigma)
and a2 [34] subunit of soluble guanylyl cyclase. Fluorescent
protein tagged sGC subunits were also detected by antibodies
against GFP (Clontech). The membranes were washed three times
for 10 min with TBST and subsequently incubated for 1 h with
horseradish peroxidase-labeled anti-rabbit IgG antibodies (Cell
Signaling). After three washes with TBST the membranes were
processed with the ECL Western blotting detection system
according to the recommendations of the manufacturer (Roche).
Protein Purification
All purification steps were performed at 4uC. The cell pellet
from 500 ml of cell solution infected with the respective
recombinant baculovirus was homogenized by sonification in
30 ml homogenization buffer containing 50 mM TEA/HCl,
pH 7.4, 10 mM DTT, 1 mM EDTA and complete
TM protease
inhibitor cocktail (Roche). Avidin (250 nM, IBA) was added to the
homogenate and incubated for 30 min at for 4uC. The
homogenate was centrifuged at 15,000 g for 2 h and 30 ml of
the supernatant was collected. All chromatographic steps were
performed on an A ¨KTA purifier system (GE Healthcare). The
supernatant was immediately applied to a Strep-TactinH Super-
flowH high capacity (4 ml volume, IBA) column (C 10/10 and
adapter AC 10, GE Healthcare) at 1 ml/min. The Strep
purification was done using the Strep-tagH Protein Purification
Buffer Set and according to manufactures protocol (IBA).
Fractions showing absorption at 280 nm were pooled and applied
immediately with a flow rate of 15 ml/min to a HiPrep 26/10
Desalting column (GE Healthcare) that was equilibrated 5 CV
with IEX-1 (50 mM TEA, 10 mM DTT, 1 mM Benzamidin,
pH 8.0) buffer before use. Elution was carried out with 2 CV at
15 ml/min with IEX-1 buffer and fractionated in 1.0 ml.
Fractions showing absorption at 280 nm were pooled and applied
immediately with a flow rat of 2 ml/min to a Mono Q 5/50 GL
column (GE Hethcare) that was equilibrated 10 CV with IEX-1
buffer before use. The column was washed (10 CV) at 2 ml/min
with IEX-1. Elution was carried out with 10 CV at 2 ml/min with
a linear gradient running from zero to 100% IEX-2 buffer
(50 mM TEA, 10 mM DTT, 1 mM Benzamidin, 1 M NaCl,
pH 8.0) and fractionated in 0.5 ml. Peak fractions showing
absorption at 280 nm were pooled and concentrated using
Amicon centrifugal filter units (30,000 MW). Purified sGC was
detected in pooled fractions using sensitive coomaissie blue
staining, analysis of absorption spectra were done on a UV-VIS
Spectrophotometer (Cary 50).
Spectrofluorometer Study of FRET
The spectrofluorometric study was carried out on a Varian
spectrofluorometer. Cytosolic fractions from Sf9 cells infected with
the respective recombinant baculovirus were investigated at 37uC
using a heated cuvette mount. For spectral analysis the spectroflu-
orometer was set at the scan mode of 1 nm wavelength intervals,
emission PMT voltage 600 V, the emission slit width and excitation
slit width 5 nm and 5 nm, respectively. For measurement of FRET
by sensitized emission using three channels the spectrofluorometer
was set at the simple reads mode of 0.2 sec integration time with an
emission PMT voltage of 600 V, the emission slit width and
excitation slit width 5 nm and 5 nm, respectively.
FRET Measurement and Calculation
FRET measurements were done using the sensitized emission
method with three channels. In the donor channel the excitation
wavelength of CFP was selected at 436 nm on the blue site of the
CFP excitation spectrum to avoid excessive cross excitation of the
acceptor YFP. The emission of CFP was detected at 476 nm. In the
acceptorchannel theexcitationwavelength ofYFPwas 515 nmand
the emission wavelength 527 nm. Therefore, the FRET channel
was selected at 436 nm excitation and 527 nm emission (see
supplementary Fig. S1). Before the determination of FRET
fluorescent samples were diluted to equal fluorescence intensity in
the YFPchannel withhomogenization buffer.In order to determine
the amount of background fluorescence due to excitation of
cytosolic components, the protein content of the diluted samples
was determined and the respective background fluorescence of
cytosolic fractions of uninfected Sf9 cells was subtracted. Using this
background subtraction the values for CFP fluorochrome in the
YFP channel and YFP fluorochrome in the CFP channel were
effectively zero. Corrected FRET (FRET
C) was calculated using the
equation: FRETC~FRET{ 0:446|CFP ðÞ { 0:0177|YFP ðÞ
(see reference[35]), where FRET, CFP, and YFP correspond to
background subtracted fluorescence intensities of cytosolic fractions
co-expressing CFP and YFP acquired through the FRET, CFP, and
YFP channels, respectively. 0.446 and 0.0177 are the fractions that
werecalculated forthebleed-throughofCFPandYFP,respectively,
through the FRET channel. These values of bleed-through were
similar to those described by other researches for the CFP/YFP pair
[36,37]. The negative FRET
C values obtained in control experi-
ments are due to slight overestimation of the bleed-through
coefficients. The corrected FRET values obtained above can be
affected by variations in CFP and YFP fluorescence intensities due
to the expression level of CFP and YFP in different samples. To
compare FRET values between different samples, the FRET
efficiency (apparent Efficiency, E%) was calculated according to the
equation: E%~1{ CFP= CFPzFRETC|Qd=Qa
 
(see refer-
ence [38,39]) where FRET
C is the corrected FRET from the
equation above and CFP corresponds to the background subtracted
fluorescence intensities of cytosolic fractions co-expressing CFP and
YFP acquired through the CFP channel, Qd and Qa are the donor
and acceptor quantum yields, respectively ( Qd=0.4, Qa=0.61).
The distance (r) between donor and acceptor molecule is
calculated using the equation:
r~R0 1=E{1 ðÞ
1=6
where R0 is the Fo ¨rster radius at which the energy transfer from
donor to acceptor is 50% (R0 CFP/YFP=4,9 nm). The Fo ¨rster radii
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assumption of complete dynamic isotropic orientational averaging




Figure S1 Normalized fluorescence excitation and emission
spectra of fluorescent proteins and fluorescent tagged sGC
subunits. Excitation spectra of ECFP (cyan dashed line) and
emission spectra of ECFP (cyan solid line), excitation spectra of
EYFP (yellow dashed line) and emission spectra of EYFP (yellow
solid line) are preserved after fusion to sGC subunits. Spectral
properties of the respective fluorescent tagged sGC subunits are
shown with black lines. Fluorescence emission spectrum of the
sGC a1YFP/b1CFP heterodimer (red line) after excitation at
436 nm. Shaded bars indicate the wavelength for excitation and
emission used in sensitized emission FRET study.
Found at: doi:10.1371/journal.pone.0011617.s001 (1.18 MB TIF)
Methods S1 Cloning of fluorescent tagged proteins and
generation of Recombinant Baculovirus.
Found at: doi:10.1371/journal.pone.0011617.s002 (0.04 MB
DOC)
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